Zevia PBC (NYSE:ZVIA) Posts Earnings Results, Beats Expectations By $0.01 EPS

Zevia PBC (NYSE:ZVIA) announced its quarterly earnings results on Wednesday. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01, Zacks reports. Zevia PBC had a negative return on equity of 30.61% and a negative net margin of 8.83%.The business had revenue of $37.87 million for the quarter, compared to analysts’ expectations of $39.96 million.

Here are the key takeaways from Zevia PBC’s conference call:

• 2025 financials improved: Net sales rose 4% to $161.3M, gross margin expanded to 48%, and adjusted EBITDA improved threefold to a -$4.7M full‑year loss with Q4 adjusted EBITDA roughly break‑even.
• 2026 outlook targets near profitability: Management guides net sales of $169M–$173M (~6% growth at midpoint) and adjusted EBITDA of -$1M to +$0.5M (Q1 guide $40M–$42M and EBITDA loss $1.6M–$1.9M); guidance assumes the planned discontinuation of the tea line (a ~1–1.5 point drag).
• Aluminum tariff headwind: The company expects an incremental ~$5M in tariff‑related aluminum costs beginning in Q2, a material margin headwind that management intends to offset with a mid‑single‑digit price increase and the final ~$5M of productivity savings hitting late Q2.
• Operational momentum—distribution, innovation, and marketing: National Costco front‑of‑store rotation, expanded Walmart and Albertsons presence, successful fruity SKU launches (e.g., Orange Creamsicle) and a package/marketing rollout are positioned to drive trial and repeat.

Zevia PBC Stock Performance

Shares of ZVIA stock traded down $0.22 during midday trading on Thursday, reaching $1.33. 281,799 shares of the company were exchanged, compared to its average volume of 974,457. Zevia PBC has a 12 month low of $1.11 and a 12 month high of $3.66. The company has a market cap of $99.90 million, a P/E ratio of -6.05 and a beta of 0.86. The company’s 50 day moving average price is $1.92 and its two-hundred day moving average price is $2.35.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ZVIA shares. Craig Hallum assumed coverage on Zevia PBC in a research note on Thursday, January 15th. They issued a “buy” rating and a $4.00 target price on the stock. Zacks Research cut shares of Zevia PBC from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 5th. Telsey Advisory Group reduced their target price on shares of Zevia PBC from $6.00 to $5.00 and set an “outperform” rating for the company in a research note on Thursday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Zevia PBC in a research report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $4.43.

Insider Activity at Zevia PBC

In related news, major shareholder De Depot Et Placement D. Caisse sold 3,500,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $2.00, for a total transaction of $7,000,000.00. Following the transaction, the insider owned 13,550,428 shares in the company, valued at $27,100,856. This trade represents a 20.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.11% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Zevia PBC

A number of hedge funds have recently modified their holdings of ZVIA. Quadrature Capital Ltd acquired a new position in shares of Zevia PBC in the fourth quarter worth about $26,000. Engineers Gate Manager LP purchased a new stake in shares of Zevia PBC in the 4th quarter valued at approximately $28,000. JPMorgan Chase & Co. lifted its position in shares of Zevia PBC by 2,460.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 15,518 shares of the company’s stock valued at $50,000 after acquiring an additional 14,912 shares in the last quarter. Bank of America Corp DE boosted its stake in Zevia PBC by 2,845.4% in the 4th quarter. Bank of America Corp DE now owns 15,817 shares of the company’s stock worth $66,000 after purchasing an additional 15,280 shares during the period. Finally, Tocqueville Asset Management L.P. purchased a new position in Zevia PBC during the 3rd quarter worth approximately $44,000. 53.21% of the stock is currently owned by institutional investors and hedge funds.

Zevia PBC Company Profile

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.